Pages that link to "Q39696487"

The following pages link to Docosahexaenoic acid alters epidermal growth factor receptor-related signaling by disrupting its lipid raft association (Q39696487):

Displaying 47 items.

• Omega-3 Fatty Acids and Cancer Cell Cytotoxicity: Implications for Multi-Targeted Cancer Therapy (Q26773056) (← links)
• Biophysical and biochemical mechanisms by which dietary N-3 polyunsaturated fatty acids from fish oil disrupt membrane lipid rafts (Q26996376) (← links)
• Experimental evidence of ω-3 polyunsaturated fatty acid modulation of inflammatory cytokines and bioactive lipid mediators: their potential role in inflammatory, neurodegenerative, and neoplastic diseases (Q27021694) (← links)
• Omega-3 fatty acids for breast cancer prevention and survivorship (Q28080498) (← links)
• Membrane Raft Organization Is More Sensitive to Disruption by (n-3) PUFA Than Nonraft Organization in EL4 and B Cells (Q30500247) (← links)
• Biospecimen long-chain N-3 PUFA and risk of colorectal cancer: a meta-analysis of data from 60,627 individuals (Q30868060) (← links)
• Interaction of dietary fatty acids with tumour necrosis factor family cytokines during colon inflammation and cancer (Q33614335) (← links)
• Key roles for GRB2-associated-binding protein 1, phosphatidylinositol-3-kinase, cyclooxygenase 2, prostaglandin E2 and transforming growth factor alpha in linoleic acid-induced upregulation of lung and breast cancer cell growth (Q34069510) (← links)
• Alteration of EGFR spatiotemporal dynamics suppresses signal transduction. (Q34326437) (← links)
• Mechanisms by Which Pleiotropic Amphiphilic n-3 PUFA Reduce Colon Cancer Risk (Q34494043) (← links)
• N-3 poly-unsaturated fatty acids shift estrogen signaling to inhibit human breast cancer cell growth (Q34534676) (← links)
• The role of n-3 polyunsaturated fatty acids in the prevention and treatment of breast cancer (Q34578129) (← links)
• Pathways of polyunsaturated fatty acid utilization: implications for brain function in neuropsychiatric health and disease (Q35117457) (← links)
• Fish Oil-Rich Diet Promotes Hematopoiesis and Alters Hematopoietic Niche. (Q35878818) (← links)
• α-linolenic acid and docosahexaenoic acid, alone and combined with trastuzumab, reduce HER2-overexpressing breast cancer cell growth but differentially regulate HER2 signaling pathways (Q35965040) (← links)
• The janus face of lipids in human breast cancer: how polyunsaturated Fatty acids affect tumor cell hallmarks (Q36090372) (← links)
• Inhibitory effects of omega-3 fatty acids on injury-induced epidermal growth factor receptor transactivation contribute to delayed wound healing (Q36836131) (← links)
• Preoperative serum docosahexaenoic acid level predicts prognosis of renal cell carcinoma (Q37000922) (← links)
• Inhibition of SREBP increases gefitinib sensitivity in non-small cell lung cancer cells (Q37588470) (← links)
• Modulation of Ras/ERK and Phosphoinositide Signaling by Long-Chain n-3 PUFA in Breast Cancer and Their Potential Complementary Role in Combination with Targeted Drugs (Q37729599) (← links)
• Omega-3 fatty acids and cancers: a systematic update review of epidemiological studies (Q38010559) (← links)
• Effects of omega-3 fatty acids on progestin stimulation of invasive properties in breast cancer (Q38029548) (← links)
• Caveolae as a target to quench autoinduction of the metastatic phenotype in lung cancer (Q38374290) (← links)
• Omega-3 polyunsaturated fatty acids and cancer: lessons learned from clinical trials. (Q38557891) (← links)
• Docosahexaenoic acid inhibits the phosphorylation of STAT3 and the growth and invasion of renal cancer cells (Q38623611) (← links)
• Pyruvate dehydrogenase alpha 1 as a target of omega-3 polyunsaturated fatty acids in human prostate cancer through a global phosphoproteomic analysis (Q38760818) (← links)
• Docosahexaenoic Acid Downregulates EGF-Induced Urokinase Plasminogen Activator and Matrix Metalloproteinase 9 Expression by Inactivating EGFR/ErbB2 Signaling in SK-BR3 Breast Cancer Cells (Q38875428) (← links)
• Sarcolemmal dependence of cardiac protection and stress-resistance: roles in aged or diseased hearts. (Q38903618) (← links)
• Docosahexaenoic acid attenuates breast cancer cell metabolism and the Warburg phenotype by targeting bioenergetic function (Q39004471) (← links)
• Docosahexaenoic Acid-mediated Inhibition of Heat Shock Protein 90-p23 Chaperone Complex and Downstream Client Proteins in Lung and Breast Cancer (Q39158772) (← links)
• Emerging role of chemoprotective agents in the dynamic shaping of plasma membrane organization (Q39200406) (← links)
• Stearoyl-CoA desaturase activity modulates the activation of epidermal growth factor receptor in human lung cancer cells (Q39285833) (← links)
• Docosahexaenoic Acid Induces Cell Death in Human Non-Small Cell Lung Cancer Cells by Repressing mTOR via AMPK Activation and PI3K/Akt Inhibition (Q40574345) (← links)
• Docosahexaenoic Acid Modulates a HER2-Associated Lipogenic Phenotype, Induces Apoptosis, and Increases Trastuzumab Action in HER2-Overexpressing Breast Carcinoma Cells (Q41846641) (← links)
• Docosahexaenoic acid enhances amphiregulin-mediated bronchial epithelial cell repair processes following organic dust exposure (Q47666065) (← links)
• Implications of dietary ω-3 and ω-6 polyunsaturated fatty acids in breast cancer. (Q50054220) (← links)
• UDP-glucose ceramide glucosyltransferase activates AKT, promoted proliferation, and doxorubicin resistance in breast cancer cells. (Q51146973) (← links)
• Growth and gene expression differ over time in alpha-linolenic acid treated breast cancer cells. (Q52961434) (← links)
• Docoxahexaenoic Acid Induces Apoptosis of Pancreatic Cancer Cells by Suppressing Activation of STAT3 and NF-κB (Q58617706) (← links)
• Omega-3 polyunsaturated fatty acids as adjuvant therapy of colorectal cancer (Q59882706) (← links)
• Nanomedicine-based formulations containing ω-3 polyunsaturated fatty acids: potential application in cardiovascular and neoplastic diseases (Q64097121) (← links)
• Functional link between plasma membrane spatiotemporal dynamics, cancer biology, and dietary membrane-altering agents. (Q64939214) (← links)
• Comparing docosahexaenoic acid (DHA) concomitant with neoadjuvant chemotherapy versus neoadjuvant chemotherapy alone in the treatment of breast cancer (DHA WIN): protocol of a double-blind, phase II, randomised controlled trial (Q90148195) (← links)
• Dysregulation of PI3K-Akt-mTOR pathway in brain of streptozotocin-induced type 2 diabetes mellitus in Wistar rats (Q90447950) (← links)
• Increased inflammatory lipid metabolism and anaplerotic mitochondrial activation follow acquired resistance to vemurafenib in BRAF-mutant melanoma cells (Q91826263) (← links)
• Krill oil extract suppresses the proliferation of colorectal cancer cells through activation of caspase 3/9 (Q92713114) (← links)
• Effects of Omega-3 Supplementation on Ki-67 and VEGF Expression Levels and Clinical Outcomes of Locally Advanced Breast Cancer Patients Treated with Neoadjuvant CAF Chemotherapy: A Randomized Controlled Trial Report (Q95728104) (← links)